ClavystBio
Asia, Central Region, Singapore, Singapore'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Description
ClavystBio invest in early-stage ventures in the biotech, medtech and digital health sectors.
Investor Profile
ClavystBio has backed more than 9 startups, with 5 new investments in the last 12 months alone. The firm has led 4 rounds, about 44% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in Singapore, United States, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 2 rounds in the past year.
Stage Focus
- Series A (44%)
- Series B (22%)
- Seed (11%)
- Series Unknown (11%)
- Series D (11%)
Country Focus
- Singapore (56%)
- United States (33%)
- The Netherlands (11%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Artificial Intelligence (Ai)
- Machine Learning
- Internet
- Health Diagnostics
- Life Science
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does ClavystBio frequently co-invest with?
What are some of recent deals done by ClavystBio?
Find More Investors Like ClavystBio
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
